SEGALL BRYANT & HAMILL, LLC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 10 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$11,000
-54.2%
30,0000.0%0.00%
Q2 2019$24,000
-31.4%
30,0000.0%0.00%
-100.0%
Q1 2019$35,000
+45.8%
30,0000.0%0.00%
Q4 2018$24,000
-61.3%
30,0000.0%0.00%
-100.0%
Q3 2018$62,000
-79.7%
30,0000.0%0.00%
-80.0%
Q2 2018$306,000
+56.9%
30,0000.0%0.01%0.0%
Q1 2018$195,000
+63.9%
30,000
+100.0%
0.01%
+66.7%
Q4 2017$119,000
-16.2%
15,0000.0%0.00%0.0%
Q3 2017$142,000
+10.9%
15,000
+50.0%
0.00%0.0%
Q2 2017$128,000
+10.3%
10,000
-9.1%
0.00%0.0%
Q1 2017$116,000
+34.9%
11,0000.0%0.00%
+50.0%
Q4 2016$86,00011,0000.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders